{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:48:30Z","timestamp":1770328110347,"version":"3.49.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"crossref","award":["2\/14.11.2018"],"award-info":[{"award-number":["2\/14.11.2018"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Colorectal cancer is a heterogeneous disease with multiple epigenetic alterations and different molecular features. The molecular classification is based on 2 major distinct pathways: microsatellite stable pathway and the microsatellite instability pathway. Molecular profiling of colorectal cancer provides important information regarding treatment and prognosis. Aim of the study was to assess the frequency of microsatellite instability in colon cancer and the clinicopathological characteristics of the tumors with high level of microsatellite instability (MSI-H) in our region. The secondary outcome was to assess the frequency of v-raf murine sarcoma viral oncogene homolog B1 (<jats:italic toggle=\"yes\">BRAF<\/jats:italic>) mutations in colon cancer.<\/jats:p>\n            <jats:p>The study included 129 patients with colon cancer fit for surgery. Demographic data, clinical and pathological data, immunohistochemistry staining pattern (4 mismatch repair proteins were investigated), and <jats:italic toggle=\"yes\">BRAF<\/jats:italic> gene mutations were assessed. According to microsatellite instability status by polymerase chain reaction, patients were divided into 3 groups: microsatellite stable (MSS)\u200a=\u200a108 patients, high level of microsatellite instability (MSI-H) = 15 patients and low level of microsatellite instability (MSI-L)\u200a=\u200a6 patients. Different clinicopathological comparisons between MSS and MSI-H patients, and between MSS and MSI-L patients were performed.<\/jats:p>\n            <jats:p>Microsatellite instability was found in 16.3% patients: 11.6% had MSI-H and 4.7% had MSI-L. Significantly more patients in the MSI-H group than in the MSS group were female (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.01) and had a family history of colon cancer (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). MSI-H and MSI-L groups were associated with the ascending colon location of the tumors, were mostly type G3, T2, and stage I whereas MSS tumors were mostly G2, pT3, and stage III. Overall, <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutations were identified in 18\/129 patients (13.9%). BRAF mutant tumors were predominantly associated with MSI-H and MSI-L tumors. Immunohistochemistry had a sensitivity of 76% and a specificity of 89% in detecting MSI tumors and an accuracy of 87.6%.<\/jats:p>\n            <jats:p>The frequency of microsatellite instability in our study was 16.3%. MSI-H is a distinct molecular phenotype of colon cancer with particular features: female gender, family history of colorectal cancer, a predilection for the ascending colon, poorly differentiated, predominantly T2, and stage I. The frequency of <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutations was 13.9% and mutations were more often present in the MSI tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024062","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:37:16Z","timestamp":1610584636000},"page":"e24062","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Molecular profiling of the colon cancer in South-Eastern Romania"],"prefix":"10.1097","volume":"100","author":[{"given":"Razvan Catalin","family":"Popescu","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta"},{"name":"Surgery Department of Constanta County Clinical Emergency Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-0630","authenticated-orcid":false,"given":"Cristina","family":"Tocia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta"},{"name":"Gastroenterology Department of Constanta County Clinical Emergency Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costel","family":"Br\u00eenzan","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology (CEDMOG), Ovidius University of Constanta."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgeta Camelia","family":"Cozaru","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology (CEDMOG), Ovidius University of Constanta."},{"name":"Pathology Department of Constanta County Clinical Emergency Hospital, Constanta, Romania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Deacu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta"},{"name":"Pathology Department of Constanta County Clinical Emergency Hospital, Constanta, Romania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Dumitru","sequence":"additional","affiliation":[{"name":"Gastroenterology Department of Constanta County Clinical Emergency Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoleta","family":"Leopa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta"},{"name":"Surgery Department of Constanta County Clinical Emergency Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca Florentina","family":"Mitroi","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology (CEDMOG), Ovidius University of Constanta."},{"name":"Pathology Department of Constanta County Clinical Emergency Hospital, Constanta, Romania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Nicolau","sequence":"additional","affiliation":[{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology (CEDMOG), Ovidius University of Constanta."},{"name":"Pathology Department of Constanta County Clinical Emergency Hospital, Constanta, Romania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Dumitru","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ovidius University of Constanta"},{"name":"Gastroenterology Department of Constanta County Clinical Emergency Hospital"},{"name":"Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology (CEDMOG), Ovidius University of Constanta."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1440-1746.2012.07200.x","article-title":"Molecular pathways in colorectal cancer","volume":"27","author":"Al-Sohaily","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","article-title":"Microsatellite instability in colorectal cancer-the stable evidence","volume":"7","author":"Vilar","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13402-011-0024-x","article-title":"Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications","volume":"34","author":"Zaanan","year":"2011","journal-title":"Cellular Oncology (Dordrecht)"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cgh.2013.11.001","article-title":"Microsatellite instability testing in colorectal carcinoma: a practical guide","volume":"12","author":"Gibson","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4251\/wjgo.v5.i2.12","article-title":"Era of universal testing of microsatellite instability in colorectal cancer","volume":"5","author":"Zhang","year":"2013","journal-title":"World J Gastrointest Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1200\/JCO.2012.46.8454","article-title":"Population-based molecular screening for Lynch syndrome: implications for personalized medicine","volume":"31","author":"Ward","year":"2013","journal-title":"J Clin Oncol"},{"key":"R10-20250504","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1007\/s13277-014-1831-2","article-title":"Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability","volume":"35","author":"Amira","year":"2014","journal-title":"Tumour Biol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2353\/jmoldx.2008.080031","article-title":"Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry","volume":"10","author":"Shia","year":"2008","journal-title":"J Mol Diagn"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/00000478-200412000-00002","article-title":"What is the best way to assess microsatellite instability status in colorectal cancer? Study on a population base of 462 colorectal cancers","volume":"28","author":"Chapusot","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1078-0432.CCR-11-2246","article-title":"Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803","volume":"18","author":"Ogino","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","article-title":"Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial","volume":"28","author":"Roth","year":"2010","journal-title":"J Clin Oncol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-05-0404","article-title":"Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers","volume":"65","author":"Samowitz","year":"2005","journal-title":"Cancer Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.2008.155473","article-title":"CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer","volume":"58","author":"Ogino","year":"2009","journal-title":"Gut"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","article-title":"Systematic review of microsatellite instability and colorectal cancer prognosis","volume":"23","author":"Popat","year":"2005","journal-title":"J Clin Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/363558a0","article-title":"Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis","volume":"363","author":"Ionov","year":"1993","journal-title":"Nature"},{"key":"R23-20250504","first-page":"5738","article-title":"Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer","volume":"63","author":"Fallik","year":"2003","journal-title":"Cancer Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1200\/JCO.2000.18.11.2193","article-title":"Population-based molecular detection of hereditary nonpolyposis colorectal cancer [published correction appears in J Clin Oncol 2000 Oct 1;18(19):3456]","volume":"18","author":"Salovaara","year":"2000","journal-title":"J Clin Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00384-004-0596-2","article-title":"Prognostic significance of microsatellite instability in sporadic colorectal cancer","volume":"19","author":"Lim","year":"2004","journal-title":"Int J Colorectal Dis"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1158\/1078-0432.CCR-05-1030","article-title":"Microsatellite instability and colorectal cancer prognosis [published correction appears in Clin Cancer Res. 2006 Jun 15;12(12):3868-9]","volume":"11","author":"Benatti","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)63994-6","article-title":"Histopathological identification of colon cancer with microsatellite instability","volume":"158","author":"Alexander","year":"2001","journal-title":"Am J Pathol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.mrfmmm.2004.05.025","article-title":"Clinicopathologic features in colorectal cancer patients with microsatellite instability","volume":"568","author":"Raut","year":"2004","journal-title":"Mutat Res"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jnci\/djq011","article-title":"Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status","volume":"102","author":"Campbell","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e0215513","DOI":"10.1371\/journal.pone.0215513","article-title":"Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer","volume":"14","author":"Nakayama","year":"2019","journal-title":"PLoS One"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4143\/crt.2012.44.3.179","article-title":"Clinico-pathologic parameters for prediction of microsatellite instability in colorectal cancer","volume":"44","author":"Jung","year":"2012","journal-title":"Cancer Res Treat"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","article-title":"Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer","volume":"342","author":"Gryfe","year":"2000","journal-title":"N Engl J Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/gut.48.6.821","article-title":"Microsatellite instability and the clinicopathological features of sporadic colorectal cancer","volume":"48","author":"Ward","year":"2001","journal-title":"Gut"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jnci\/92.7.544","article-title":"Standardized approach for microsatellite instability detection in colorectal carcinomas","volume":"92","author":"Gonz\u00e1lez-Garc\u00eda","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R36-20250504","first-page":"1166","article-title":"Low-level microsatellite instability in most colorectal carcinomas","volume":"62","author":"Laiho","year":"2002","journal-title":"Cancer Res"},{"key":"R37-20250504","first-page":"7743","article-title":"High frequency of low-level microsatellite instability in early colorectal cancer","volume":"61","author":"Kambara","year":"2001","journal-title":"Cancer Res"},{"key":"R38-20250504","first-page":"827","article-title":"Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability","volume":"61","author":"Whitehall","year":"2001","journal-title":"Cancer Res"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1634\/theoncologist.2009-0233","article-title":"Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery","volume":"15","author":"Tejpar","year":"2010","journal-title":"Oncologist"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"e65995","DOI":"10.1371\/journal.pone.0065995","article-title":"The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: a meta-analysis","volume":"8","author":"Yuan","year":"2013","journal-title":"PLoS One"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1463-1318.2007.01378.x","article-title":"Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency","volume":"10","author":"Jensen","year":"2008","journal-title":"Colorectal Dis"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.37358\/RC.19.4.7124","article-title":"The mutation profiles of KRAS and BRAF genes in a Romanian colorectal cancer cohort","volume":"70","author":"Br\u00eenzan","year":"2019","journal-title":"Rev Chim"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/jnci\/djt173","article-title":"Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication","volume":"105","author":"Lochhead","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.gastro.2014.09.038","article-title":"Association between molecular subtypes of colorectal cancer and patient survival","volume":"148","author":"Phipps","year":"2015","journal-title":"Gastroenterology"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11864-015-0348-2","article-title":"Microsatellite instability testing and its role in the management of colorectal cancer","volume":"16","author":"Kawakami","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"R46-20250504","first-page":"4836","article-title":"Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes","volume":"56","author":"Thibodeau","year":"1996","journal-title":"Cancer Res"},{"key":"R47-20250504","first-page":"1431","article-title":"Comparison of microsatellite status detection methods in colorectal carcinoma","volume":"11","author":"Chen","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"R48-20250504","first-page":"1487","article-title":"Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition","volume":"19","author":"Banias","year":"2020","journal-title":"Oncol Lett"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"e18122","DOI":"10.1097\/MD.0000000000018122","article-title":"Molecular expression profiles of selected microRNAs in colorectal adenocarcinoma in patients from south-eastern part of Romania","volume":"98","author":"Br\u00eenzan","year":"2019","journal-title":"Medicine"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:25:46Z","timestamp":1746339946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024062"}},"subtitle":["Results from the MERCUR study"],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024062","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"2020-08-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}